Weiss Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Weiss Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-27,286	Closed	-$2.27M	–	260
2023 Q2	$2.27M	Buy	+27,286	New	+$2.28M	0.17%	76
2022 Q3	–	Sell	-32,137	Closed	-$2.39M	–	698
2022 Q2	$2.39M	Buy	+32,137	New	+$2.41M	0.06%	352
2020 Q1	–	Sell	-31,800	Closed	-$3.02M	–	325
2019 Q4	$3.02M	Sell	31,800 -134,200	-81%	-$11.6M	0.2%	74
2019 Q3	$12.7M	Buy	+166,000	New	+$13.8M	1.01%	28

Other funds holding XBI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Weiss Asset Management's XBI Position: Q3 2023 in Review

Weiss Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 27,286 shares — an estimated $2.27M sold.

Weiss Asset Management first reported a position in XBI in Q3 2019 and held it in 4 quarters. The position peaked at $12.7M in Q3 2019. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Weiss Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Weiss Asset Management sold 27,286 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $2.27M.
Weiss Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2019 and held it in 4 quarters.
Weiss Asset Management's State Street SPDR S&P Biotech ETF position peaked at $12.7M in Q3 2019.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Weiss Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.